Distinct frequencies and mutation spectrums of genetic thrombophilia in Korea in comparison with other Asian countries both in patients with thromboembolism and in the general population

Haematologica

Volumn 99, Issue 3, 2014, Pages 561-569

  Kim, Hee Jin ^a   Seo, Ja Young ^a   Lee, Ki O ^b   Bang, Sung Hwan ^a   Lee, Seung Tae ^a   Ki, Chang Seok ^a   Kim, Jong Won ^a   Jung, Chul Won ^a   Kim, Duk Kyung ^a   Kim, Sun Hee ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; PROTEIN C; PROTEIN S 100; ANTITHROMBIN III; PLASMA PROTEIN; PROS1 PROTEIN, HUMAN; SERPINC1 PROTEIN, HUMAN;

ADULT; ANTITHROMBIN DEFICIENCY; ARTICLE; BLOOD CLOTTING TEST; CLINICAL EVALUATION; DNA EXTRACTION; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC EPIDEMIOLOGY; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR GENETICS; THROMBOPHILIA; VENOUS THROMBOEMBOLISM; ASIA; GENETIC PREDISPOSITION; GENETICS; MUTATION; SOUTH KOREA; THROMBOEMBOLISM;

ADULT; ANTITHROMBIN III; ASIA; BLOOD PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; PROTEIN C; REPUBLIC OF KOREA; THROMBOEMBOLISM; VENOUS THROMBOEMBOLISM;

EID: 84895732697     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.092023     Document Type: Article

References (50)

1. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood. 1996;87(9):3531-44.
2. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med. 2001;344(16):1222-31.
3. Brouwer JL, Lijfering WM, Ten Kate MK, Kluin-Nelemans HC, Veeger NJ, van der Meer J. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin. Thromb Haemost. 2009;101(1):93-9.
4. Lijfering WM, Brouwer JL, Veeger NJ, Bank I, Coppens M, Middeldorp S, et al. Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood. 2009;113(21):5314-22.
5. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh. 1965;13:516-30.
6. Dahlback B. Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood. 2008;112(1):19-27.
7. Angchaisuksiri P. Venous thromboembolism in Asia--an unrecognised and under-treated problem? Thromb Haemost. 2011;106(4): 585-90.
8. White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res. 2009;123 (Suppl 4):S11-7.
9. De Stefano V, Rossi E, Paciaroni K, Leone G. Screening for inherited thrombophilia: indications and therapeutic implications. Haematologica. 2002;87(10):1095-108.
10. Jang JH, Seo JY, Bang SH, Park IA, Kim HJ, Kim SH. Establishment of reference intervals for von Willebrand factor antigen and eight coagulation factors in a Korean population following the Clinical and Laboratory Standards Institute guidelines. Blood Coagul Fibrinolysis. 2010;21(3):251-5.
11. Kim HJ, Kim DK, Yoo KY, You CW, Yoo JH, Lee KO, et al. Heterogeneous lengths of copy number mutations in human coagulopathy revealed by genome-wide high-density SNP array. Haematologica. 2012;97(2): 304-9.
12. Tait RC, Walker ID, Islam SI, McCall F, Conkie JA, Mitchell R, et al. Influence of demographic factors on antithrombin III activity in a healthy population. Br J Haematol. 1993;84(3):476-80.
13. Tait RC, Walker ID, Perry DJ, Islam SI, Daly ME, McCall F, et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol. 1994;87(1):106-12.
14. Suehisa E, Nomura T, Kawasaki T, Kanakura Y. Frequency of natural coagulation inhibitor (antithrombin III, protein C and protein S) deficiencies in Japanese patients with spontaneous deep vein thrombosis. Blood Coagul Fibrinolysis. 2001;12(2):95-9.
15. Sakata T, Okamoto A, Mannami T, Matsuo H, Miyata T. Protein C and antithrombin deficiency are important risk factors for deep vein thrombosis in Japanese. J Thromb Haemost. 2004;2(3):528-30.
16. Zhu T, Ding Q, Bai X, Wang X, Kaguelidou F, Alberti C, et al. Normal ranges and genetic variants of antithrombin, protein C and protein S in the general Chinese population. Results of the Chinese Hemostasis Investigation on Natural Anticoagulants Study I Group. Haematologica. 2011;96(7): 1033-40.
17. Matsuda M, Sugo T, Sakata Y, Murayama H, Mimuro J, Tanabe S, et al. A thrombotic state due to an abnormal protein C. N Engl J Med. 1988;319(19):1265-8.
18. Miyata T, Zheng YZ, Sakata T, Tsushima N, Kato H. Three missense mutations in the protein C heavy chain causing type I and type II protein C deficiency. Thromb Haemost. 1994;71(1):32-7.
19. Grundy C, Chitolie A, Talbot S, Bevan D, Kakkar V, Cooper DN. Protein C London 1: recurrent mutation at Arg 169 (CGG----TGG) in the protein C gene causing thrombosis. Nucleic Acids Res. 1989;17(24):10513.
20. Tsay W, Greengard JS, Montgomery RR, McPherson RA, Fucci JC, Koerper MA, et al. Genetic mutations in ten unrelated American patients with symptomatic type 1 protein C deficiency. Blood Coagul Fibrinolysis. 1993;4(5):791-6.
21. Sakata T, Kario K, Katayama Y, Matsuyama T, Kato H, Miyata T. Studies on congenital protein C deficiency in Japanese: prevalence, genetic analysis, and relevance to the onset of arterial occlusive diseases. Semin Thromb Hemost. 2000;26(1):11-6.
22. Koide T, Odani S, Takahashi K, Ono T, Sakuragawa N. Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability. Proc Natl Acad Sci USA. 1984;81(2):289-93.
23. Okajima K, Abe H, Maeda S, Motomura M, Tsujihata M, Nagataki S, et al. Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis. Blood. 1993;81(5): 1300-5.
24. Antithrombin Mutation Database (http://www1.imperial.ac.uk/departmentofmedicine/ divisions/experimentalmedicine/ haematology/coag/antithrombin/).
25. Patnaik MM, Moll S. Inherited antithrombin deficiency: a review. Haemophilia. 2008; 14(6):1229-39.
26. Kimura R, Honda S, Kawasaki T, Tsuji H, Madoiwa S, Sakata Y, et al. Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients. Blood. 2006;107(4):1737-8.
27. Kimura R, Sakata T, Kokubo Y, Okamoto A, Okayama A, Tomoike H, et al. Plasma protein S activity correlates with protein S genotype but is not sensitive to identify K196E mutant carriers. J Thromb Haemost. 2006; 4(9):2010-3.
28. Miyata T, Sato Y, Ishikawa J, Okada H, Takeshita S, Sakata T, et al. Prevalence of genetic mutations in protein S, protein C and antithrombin genes in Japanese patients with deep vein thrombosis. Thromb Res. 2009;124(1):14-8.
29. Yamazaki T, Sugiura I, Matsushita T, Kojima T, Kagami K, Takamatsu J, et al. A phenotypically neutral dimorphism of protein S: the substitution of Lys155 by Glu in the second EGF domain predicted by an A to G base exchange in the gene. Thromb Res. 1993; 70(5):395-403.
30. Hayashi T, Nishioka J, Shigekiyo T, Saito S, Suzuki K. Protein S Tokushima: abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth factorlike domain of protein S. Blood. 1994;83 (3):683-90.
31. Sakata T, Okamoto A, Mannami T, Tomoike H, Miyata T. Prevalence of protein S deficiency in the Japanese general population: the Suita Study. J Thromb Haemost. 2004;2(6):1012-3.
32. Tang L, Guo T, Yang R, Mei H, Wang H, Lu X, et al. Genetic background analysis of protein C deficiency demonstrates a recurrent mutation associated with venous thrombo-sis in Chinese population. PLoS One. 2012;7(4):e35773.
33. Tang L, Lu X, Yu JM, Wang QY, Yang R, Guo T, et al. PROC c.574_576del polymorphism: a common genetic risk factor for venous thrombosis in the Chinese population. J Thromb Haemost. 2012;10(10):2019-26.
34. Corral J, Hernandez-Espinosa D, Soria JM, Gonzalez-Conejero R, Ordonez A, Gonzalez-Porras JR, et al. Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis. Blood. 2007;109(10):4258-63.
35. Zhang GS, Tang YM, Tang MQ, Qing ZJ, Shu C, Tang XQ, et al. Antithrombin Cambridge II(A384S) mutation frequency and antithrombin activity levels in 120 of deep venous thrombosis and 150 of cerebral infarction patients in a single center in Southern China. Blood Coagul Fibrinolysis. 2010;21(6):588-91.
36. Lee M, No HJ, Jang SY, Kim N, Choi SH, Kim H, et al. Hereditary thrombophilia in Korean patients with idiopathic pulmonary embolism. Yonsei Med J. 2012;53(3):571-7.
37. Miletich J, Sherman L, Broze G Jr. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med. 1987;317(16):991-6.
38. Tait RC, Walker ID, Reitsma PH, Islam SI, McCall F, Poort SR, et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost. 1995;73(1):87-93.
39. Dykes AC, Walker ID, McMahon AD, Islam SI, Tait RC. A study of protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol. 2001;113(3):636-41.
40. Beauchamp NJ, Dykes AC, Parikh N, Campbell Tait R, Daly ME. The prevalence of, and molecular defects underlying, inherited protein S deficiency in the general population. Br J Haematol. 2004;125(5): 647-54.
41. Koster T, Rosendaal FR, Briet E, van der Meer FJ, Colly LP, Trienekens PH, et al. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study). Blood. 1995;85(10):2756-61.
42. Faioni EM, Valsecchi C, Palla A, Taioli E, Razzari C, Mannucci PM. Free protein S deficiency is a risk factor for venous thrombosis. Thromb Haemost. 1997;78(5):1343-6.
43. Kottke-Marchant K, Comp P. Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor. Arch Pathol Lab Med. 2002;126(11):1337-48.
44. Marlar RA, Adcock DM, Madden RM. Hereditary dysfunctional protein C molecules (type II): assay characterization and proposed classification. Thromb Haemost. 1990;63(3):375-9.
45. Goodwin AJ, Rosendaal FR, Kottke-Marchant K, Bovill EG. A review of the technical, diagnostic, and epidemiologic considerations for protein S assays. Arch Pathol Lab Med. 2002;126(11):1349-66.
46. Caspers M, Pavlova A, Driesen J, Harbrecht U, Klamroth R, Kadar J, et al. Deficiencies of antithrombin, protein C and protein S-practical experience in genetic analysis of a large patient cohort. Thromb Haemost. 2012;108 (2):247-57.
47. Cooper PC, Goodeve AC, Beauchamp NJ. Quality in molecular biology testing for inherited thrombophilia disorders. Semin Thromb Hemost. 2012;38(6):600-12.
48. Human Genome Mutation Database (HGMD® Professional) [Internet]. BIOBASE GmbH. Available at: http://www.biobaseinternational. com/product/hgmd.
49. Kim HJ, Kim DK, Koh KC, Kim JY, Kim SH. Severe protein C deficiency from compound heterozygous mutations in the PROC gene in two Korean adult patients. Thromb Res. 2008;123(2):412-7.
50. Tripodi A, Franchi F, Krachmalnicoff A, Mannucci PM. Asymptomatic homozygous protein C deficiency. Acta Haematol. 1990;83(3):152-5.